Gouty arthritis in acute cerebrovascular disease

Cerebrovascular Diseases

Volumn 28, Issue 4, 2009, Pages 391-396

  Lin, Ya Hui ^a   Hsu, Huan Lin ^a   Huang, Ying Chih ^a   Lee, Meng ^a   Huang, Wen Yi ^b   Huang, Yen Chu ^a   Lee, Tsong Hai ^c   Lee, Jiann Der ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Keelung branch ^*

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Acute ischemic stroke; Cerebrovascular disease, rehabilitation; Gout

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; BENZBROMARONE; DIURETIC AGENT; URIC ACID;

ADULT; AGED; ALCOHOL CONSUMPTION; ANKLE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GOUT; GROUPS BY AGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE; KNEE; LEG; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SMOKING; TAIWAN; TOE; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, GOUTY; BRAIN ISCHEMIA; FEMALE; HOSPITALIZATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERURICEMIA; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TAIWAN; TIME FACTORS;

EID: 68949116051     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235626     Document Type: Article

References (48)

1. Wortmann RL, Kelley WN: Gout and hyperuricemia; in Harris ED Jr, Budd RC, Genovese MC, Firestein GS, Sergent JS, Sledge CB (eds): Kelley's Textbook of Rheumatology. Philadelphia, Saunders, 2005, pp 1403- 1419
2. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH: Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994; 21: 302-306
3. Chu NF, Wang DJ, Liou SH, Shieh SM: Relationship between hyperuricemia and other cardiovascular disease risk factors among adult males in Taiwan. Eur J Epidemiol 2000; 16: 13-17
4. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM: Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam Study. Stroke 2006; 37: 1503-1507 (Pubitemid 44305733)
5. Koton S, Howard SC, Warlow CP, Murphy MF, Rothwell PM: Serum urate predicts long-term risk of acute coronary events in women after a transient ischaemic attack and stroke. Cerebrovasc Dis 2008; 26: 517-524
6. Guan MP, Xue YM, Shen J, Zhou L, Gao F, Liu SQ, Li CZ: Serum uric acid in type 2 diabetic patients complicated by stroke. Di Yi Jun Yi Da Xue Xue Bao 2002; 22: 70-71
7. Milionis HJ, Kalantzi KJ, Goudevenos JA, Seferiadis K, Mikhailidis DP, Elisaf MS: Serum uric acid levels and risk for acute ischaemic non-embolic stroke in elderly subjects. J Intern Med 2005; 258: 435-441
8. Hozawa A, Folsom AR, Ibrahim H, Javier Nieto F, Rosamond WD, Shahar E: Serum uric acid and risk of ischemic stroke: The ARIC study. Atherosclerosis 2006; 187: 401-407
9. Krishnan E, Baker JF, Furst DE, Schumacher HR: Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006; 54: 2688-2696
10. Chen SY, Chen CL, Shen ML: Severity of gouty arthritis is associated with q-wave myocardial infarction: A large-scale, crosssectional study. Clin Rheumatol 2007; 26: 308-313
11. Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M: Gout, just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract 2003; 20: 413-416
12. Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH: Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008; 168: 1104-1110
13. Choi HK, Curhan G: Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116: 894-900
14. Langhorne P, Stott DJ, Robertson L, Mac- Donald J, Jones L, McAlpine C, Dick F, Taylor GS, Murray G: Medical complications after stroke: a multicenter study. Stroke 2000; 31: 1223-1229
15. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-1526
16. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF: Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900
17. Chang SJ, Ko YC, Wang TN, Chang FT, Cinkotai FF, Chen CJ: High prevalence of gout and related risk factors in Taiwan's aborigines. J Rheumatol 1997; 24: 1364-1369
18. Kim KY, Ralph Schumacher H, Hunsche E, Wertheimer AI, Kong SX: A literature review of the epidemiology and treatment of acute gout. Clin Ther 2003; 25: 1593-1617
19. Luk AJ, Simkin PA: Epidemiology of hyperuricemia and gout. Am J Manag Care 2005; 11:S435-S442, quiz S465-S468
20. Chen SY, Chen CL, Shen ML, Kamatani N: Trends in the manifestations of gout in Taiwan. Rheumatology (Oxford) 2003; 42: 1529-1533
21. De Souza AW, Fernandes V, Ferrari AJ: Female gout: Clinical and laboratory features. J Rheumatol 2005; 32: 2186-2188
22. Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, Von Worley A, Platt R, Saag KG: Sex differences in gout epidemiology: Evaluation and treatment. Ann Rheum Dis 2006; 65: 1368-1372
23. Wise CM: Crystal-associated arthritis in the elderly. Rheum Dis Clin North Am 2007; 33: 33-55
24. Feldman EB, Wallace SL: Hypertriglyceridemia in gout. Circulation 1964; 29: 508-513
25. Jiao S, Kameda K, Matsuzawa Y, Tarui S: Hyperlipoproteinaemia in primary gout: Hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan. Ann Rheum Dis 1986; 45: 308-313
26. Emmerson B: Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 1998; 57: 509-510
27. Chou CT, Chao PM: Lipid abnormalities in Taiwan Aborigines with gout. Metabolism 1999; 48: 131-133
28. Takahashi S, Yamamoto T, Moriwaki Y, Tsutsumi Z, Higashino K: Impaired lipoprotein metabolism in patients with primary gout - influence of alcohol intake and body weight. Br J Rheumatol 1994; 33: 731-734
29. Chen SY, Chen CL, Shen ML: Manifestations of metabolic syndrome associated with male gout in different age strata. Clin Rheumatol 2007; 26: 1453-1457
30. DeFronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194
31. Campion EW, Glynn RJ, DeLabry LO: Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am J Med 1987; 82: 421-426
32. Agudelo CA, Wise CM: Crystal-associated arthritis. Clin Geriatr Med 1998; 14: 495-513
33. Choi HK, Atkinson K, Karlson EW, Curhan G: Obesity, weight change, hypertension, diuretic use, and risk of gout in men: The Health Professionals Follow-Up Study. Arch Intern Med 2005; 165: 742-748
34. Gibson T, Highton J, Potter C, Simmonds HA: Renal impairment and gout. Ann Rheum Dis 1980; 39: 417-423
35. Perez-Ruiz F, Calabozo M, Herrero-Beites AM, Garcia-Erauskin G, Pijoan JI: Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 2000; 86: 287-291
36. Nickeleit V, Mihatsch MJ: Uric acid nephropathy and end-stage renal disease review of a non-disease. Nephrol Dial Transplant 1997; 12: 1832-1838
37. Manttari M, Tiula E, Alikoski T, Manninen V: Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995; 26: 670-675
38. Henry D, Page J, Whyte I, Nanra R, Hall C: Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects: Results of a case-control study. Br J Clin Pharmacol 1997; 44: 85-90
39. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez- Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190
40. Yu TF, Gutman AB: Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest 1959; 38: 1298-1315
41. Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R: The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000; 43: 103-108
42. Segal R, Lubart E, Leibovitz A, Berkovitch M, Habot B, Yaron M, Caspi D: Early and late effects of low-dose aspirin on renal function in elderly patients. Am J Med 2003; 115: 462-466
43. Segal R, Lubart E, Leibovitz A, Iaina A, Caspi D: Renal effects of low dose aspirin in elderly patients. Isr Med Assoc J 2006; 8: 679-682
44. Winter S: Unilateral Heberden's nodes in a case of hemiplegia. NY State J Med 1952; 52: 349-350
45. Keyszer G, Langer T, Kornhuber M, Taute B, Horneff G: Neurovascular mechanisms as a possible cause of remission of rheumatoid arthritis in hemiparetic limbs. Ann Rheum Dis 2004; 63: 1349-1351
46. Courtright LJ, Kuzell WC: Sparing effect of neurological deficit and trauma on the course of adjuvant arthritis in the rat. Ann Rheum Dis 1965; 24: 360-368
47. Chakravarty K, Durkin CJ, al-Hillawi AH, Bodley R, Webley M: The incidence of acute arthritis in stroke patients, and its impact on rehabilitation. Q J Med 1993; 86: 819-823
48. Donegan CF, Berman P, Doherty M: Rapid development of a tophus following ipsilateral hemiparesis. Ann Rheum Dis 1993; 52: 308-309